After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Biomedical Ethics and Regulatory Capacity Building: International Dialogues

The LiberHetica and BERC-Luso consortia will meet on the 26th March 2021 to discuss about Biomedical Ethics and Regulatory Capacity Building in Sub-Saharan African countries. The LiberHetica and BERC-Luso are two projects funded by

Read More

Tenth EDCTP Forum October 2021: Equity in Research for Health

The Tenth biennal EDCTP Forum took place virtually, because of COVID-19 pandemic, from 17th to 21st  October 2021, hosted by the National Institute of Health (INS), Mozambique and the Health Research Centre

Read More

R-Evolution Sierra Leone

R-Evolution Worldwide Sierra Leone is a Local Voluntary Organization of Sierra Leoneans established to help and support vulnerable children, youth, women and communities to build a brighter future in changing

Read More